Hinge Health, Inc. (HNGE)
NYSE: HNGE · Real-Time Price · USD
50.04
+0.38 (0.77%)
Dec 5, 2025, 4:00 PM EST - Market closed
Hinge Health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Net Income | -533.24 | -11.93 | -108.14 |
| Depreciation & Amortization | 2.18 | 2.35 | 2.13 |
| Other Amortization | 44.57 | 33.51 | 23.84 |
| Loss (Gain) From Sale of Investments | 0.62 | 0.54 | -10.76 |
| Stock-Based Compensation | 625.85 | 0.74 | 1.65 |
| Provision & Write-off of Bad Debts | 4.81 | 5.41 | 4.86 |
| Other Operating Activities | 2.98 | 4.88 | 13.11 |
| Change in Accounts Receivable | -31.72 | -1.34 | -23.13 |
| Change in Inventory | -6.16 | 0.61 | 10.57 |
| Change in Accounts Payable | 22.17 | -10.98 | 11.56 |
| Change in Unearned Revenue | 89.62 | 77.16 | 35.97 |
| Change in Other Net Operating Assets | -75.78 | -51.95 | -25.56 |
| Operating Cash Flow | 145.89 | 49 | -63.91 |
| Capital Expenditures | -0.46 | -1.04 | -1.98 |
| Sale (Purchase) of Intangibles | -4.27 | -2.73 | -2.64 |
| Investment in Securities | -70.45 | 22.09 | 6.12 |
| Investing Cash Flow | -79.18 | 18.31 | 1.5 |
| Issuance of Common Stock | 256.67 | 0.61 | 0.49 |
| Other Financing Activities | -57.67 | -2.81 | -3.49 |
| Financing Cash Flow | -73.26 | -2.2 | -3 |
| Net Cash Flow | -6.55 | 65.11 | -65.41 |
| Free Cash Flow | 145.43 | 47.96 | -65.89 |
| Free Cash Flow Margin | 27.21% | 12.29% | -22.51% |
| Free Cash Flow Per Share | 3.82 | 3.54 | -5.06 |
| Levered Free Cash Flow | - | 73.18 | - |
| Unlevered Free Cash Flow | - | 73.18 | - |
| Change in Working Capital | -1.87 | 13.5 | 9.41 |
Source: S&P Capital IQ. Standard template.
Financial Sources.